Inclisiran plus statins for fragile heart plaque
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if adding inclisiran to your current statin can reduce dangerous, rupture-prone plaque in your heart arteries. It may help if you have a moderate blockage with thin-cap plaque and your LDL cholesterol stays high despite statins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 80 years old
- Have at least one vulnerable (high-risk) plaque in a heart artery confirmed by special imaging
- Been on a statin for at least 4 weeks but still have high LDL (≥70 mg/dL or 1.8 mmol/L)
- No heart attack in the last 30 days
- No serious kidney, liver, or heart failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a powerful cholesterol-lowering drug (PCSK9 inhibitor) helps stabilize plaque in heart arteries after a recent heart attack or unstable angina treated with a stent. It may lower the risk of future heart problems.
This study tests a new medicine called inclisiran (a small interfering RNA) to see if it can shrink or stabilize fatty plaques in neck arteries. You may qualify if you have carotid plaques and high LDL cholesterol despite statin use or if you haven't taken statins.
This study tests if starting inclisiran soon after a heart attack helps lower cholesterol further in patients already on statins. The goal is to see if early treatment can reduce future heart risks.
This study tests a new injectable medicine called inclisiran for people who are already on many medications and have high cholesterol. It is designed for those who cannot lower their cholesterol enough with statins, especially if they have diabetes or other heart risks.
This trial tests if giving inclisiran early after a heart attack can lower cholesterol more effectively. It is for people who have had a recent heart attack and still have high LDL cholesterol despite taking statins.
This study tests whether a twice-yearly injection called inclisiran can prevent heart attacks, strokes, or leg complications in people who recently had a procedure to open a blocked artery. You may be eligible if you had a heart or leg artery procedure within the last two weeks.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.